Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

774 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Authors' Reply to Noguchi et al. Comment on: "Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors Used in Patients with Diabetes and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database".
Sakamoto T, Miyamoto H, Hashizume J, Akamatsu H, Akagi T, Kodama Y, Hamano H, Zamami Y, Ohyama K. Sakamoto T, et al. Among authors: ohyama k. Clin Drug Investig. 2024 Dec 24. doi: 10.1007/s40261-024-01414-7. Online ahead of print. Clin Drug Investig. 2024. PMID: 39718696 No abstract available.
Immune complexome analysis reveals an autoimmune signature predictive of COVID-19 severity.
Moriishi M, Takazono T, Hashizume J, Aibara N, Kutsuna YJ, Okamoto M, Sawai T, Hoshino T, Mori Y, Fukuda Y, Awaya Y, Yamanashi H, Furusato Y, Yanagihara T, Miyamoto H, Sato K, Kodama Y, Mizukami S, Sakamoto N, Yamamoto K, Sakamoto K, Yanagihara K, Izumikawa K, Maeda T, Nakashima M, Fukushima K, Mukae H, Ohyama K. Moriishi M, et al. Among authors: ohyama k. Clin Biochem. 2024 Dec 15;135:110865. doi: 10.1016/j.clinbiochem.2024.110865. Online ahead of print. Clin Biochem. 2024. PMID: 39689808
Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database.
Sakamoto T, Miyamoto H, Hashizume J, Akamatsu H, Akagi T, Kodama Y, Hamano H, Zamami Y, Ohyama K. Sakamoto T, et al. Among authors: ohyama k. Clin Drug Investig. 2024 Oct;44(10):761-771. doi: 10.1007/s40261-024-01394-8. Epub 2024 Oct 14. Clin Drug Investig. 2024. PMID: 39402407
Using a Quality Management System and Risk-based Approach in Observational Studies to Obtain Robust Real-World Evidence.
Tanoshima R, Inagaki N, Nitta M, Sue S, Shimizu S, Haze T, Senuki K, Sano C, Takase H, Kaneko M, Nozaki A, Okada K, Ohyama K, Kawaguchi A, Kobayashi Y, Oi H, Maeda S, Yano Y, Kumagai Y, Miyagi E. Tanoshima R, et al. Among authors: ohyama k. Ther Innov Regul Sci. 2024 Nov;58(6):1006-1013. doi: 10.1007/s43441-024-00695-6. Epub 2024 Sep 3. Ther Innov Regul Sci. 2024. PMID: 39227522
774 results